6037 Subunit VI of Photosystem I reaction centre
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 0 | 6.3 | 0 | q = 7.4e-4 | |
| Lipids and lipid-like molecules | 12 | 1.4 | 8.41× | not tested | |
| Organoheterocyclic compounds | 12 | 2.0 | 6.08× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02133 | CLA | Chlorophyll A | 31 |
| DB06755 | BCR | Beta carotene | 29 |
| DB03279 | LMU | Dodecyl-Alpha-D-Maltoside | 4 |
| DB02043 | LHG | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLA | CHLOROPHYLL A | 49 |
| BCR | BETA-CAROTENE | 21 |
| LHG | 1,2-DIPALMITOYL-PHOSPHATIDYL-GLYCEROLE | 5 |
| LMG | 1,2-DISTEAROYL-MONOGALACTOSYL-DIGLYCERIDE | 3 |
| LMU | DODECYL-ALPHA-D-MALTOSIDE | 3 |
| SQD | 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL | 3 |
| 8CT | (6'R,11cis,11'cis,13cis,15cis)-4',5'-didehydro-5',6'-dihydro-beta,beta-carotene | 2 |
| CL0 | CHLOROPHYLL A ISOMER | 2 |
| NEX | (1R,3R)-6-{(3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1S,4R,6R)-4-HYDROXY-2,2,6-TRIMETHYL-7-OXABICYCLO[4.1.0]HEPT-1-YL]-3,7,12,16-TETRAMETHYLOCTADECA-1,3,5,7,9,11,13,15,17-NONAENYLIDENE}-1,5,5-TRIMETHYLCYCLOHEXANE-1,3-DIOL | 1 |